So it's still on the table. Plibbers' decision has not changed, but sounds like Albo and Minns might be looking for a "workaround".BTW, I am mainly in agreement that "secret business" has to be set aside sometimes for the good of all.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status
